415 related articles for article (PubMed ID: 1380203)
1. Reduced expression of CD20 antigen as a characteristic marker for chronic lymphocytic leukemia.
Almasri NM; Duque RE; Iturraspe J; Everett E; Braylan RC
Am J Hematol; 1992 Aug; 40(4):259-63. PubMed ID: 1380203
[TBL] [Abstract][Full Text] [Related]
2. CD20 and CD5 expression in B-chronic lymphocytic leukemia.
Marti GE; Faguet G; Bertin P; Agee J; Washington G; Ruiz S; Carter P; Zenger V; Vogt R; Noguchi P
Ann N Y Acad Sci; 1992 May; 651():480-3. PubMed ID: 1376065
[TBL] [Abstract][Full Text] [Related]
3. Relationship between chronic lymphocytic leukemia and small lymphocytic lymphoma. A comparative study of membrane phenotypes in 270 cases.
Batata A; Shen B
Cancer; 1992 Aug; 70(3):625-32. PubMed ID: 1623477
[TBL] [Abstract][Full Text] [Related]
4. Pan B-cell markers are not redundant in analysis of chronic lymphocytic leukemia (CLL).
Monaghan SA; Peterson LC; James C; Marszalek L; Khoong A; Bachta DJ; Karpus WJ; Goolsby CL
Cytometry B Clin Cytom; 2003 Nov; 56(1):30-42. PubMed ID: 14582135
[TBL] [Abstract][Full Text] [Related]
5. Immunophenotype does not correlate with lymph node histology in chronic lymphocytic leukemia/small lymphocytic lymphoma.
Asplund SL; McKenna RW; Howard MS; Kroft SH
Am J Surg Pathol; 2002 May; 26(5):624-9. PubMed ID: 11979092
[TBL] [Abstract][Full Text] [Related]
6. Large cell lymphoma transformation of chronic lymphocytic leukemia/small lymphocytic lymphoma. A flow cytometric analysis of seven cases.
Kroft SH; Dawson DB; McKenna RW
Am J Clin Pathol; 2001 Mar; 115(3):385-95. PubMed ID: 11242795
[TBL] [Abstract][Full Text] [Related]
7. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
Kusenda J; Babusíková O
Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of CD11c+CD5+ chronic B-cell leukemias and the identification of novel peripheral blood B-cell subsets with chronic lymphoid leukemia immunophenotypes.
Wormsley SB; Baird SM; Gadol N; Rai KR; Sobol RE
Blood; 1990 Jul; 76(1):123-30. PubMed ID: 1694698
[TBL] [Abstract][Full Text] [Related]
9. The utility of CD20 and CD43 in subclassification of low-grade B-cell lymphoma on paraffin sections.
Contos MJ; Kornstein MJ; Innes DJ; Ben-Ezra J
Mod Pathol; 1992 Nov; 5(6):631-3. PubMed ID: 1285443
[TBL] [Abstract][Full Text] [Related]
10. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
[TBL] [Abstract][Full Text] [Related]
11. Residual cancer lymphocytes in patients with chronic lymphocytic leukemia after therapy show increased expression of surface antigen CD52 detected using quantitative fluorescence cytometry.
Pevna M; Doubek M; Coupek P; Stehlikova O; Klabusay M
Clin Lymphoma Myeloma Leuk; 2014 Oct; 14(5):411-8. PubMed ID: 25066039
[TBL] [Abstract][Full Text] [Related]
12. Normal B cell compartment in chronic lymphatic leukemia.
Pluta A; Górski A; Nowaczyk M; Modlińska M
Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
[TBL] [Abstract][Full Text] [Related]
13. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
14. Quantitative flow cytometry for the differential diagnosis of leukemic B-cell chronic lymphoproliferative disorders.
D'Arena G; Musto P; Cascavilla N; Dell'Olio M; Di Renzo N; Carotenuto M
Am J Hematol; 2000 Aug; 64(4):275-81. PubMed ID: 10911380
[TBL] [Abstract][Full Text] [Related]
15. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset.
Quintanilla-Martinez L; Preffer F; Rubin D; Ferry JA; Harris NL
Am J Clin Pathol; 1994 Oct; 102(4):483-9. PubMed ID: 7524302
[TBL] [Abstract][Full Text] [Related]
16. [Expression of CD5 antigen in B and T cells from umbilical cord blood, from blood of healthy adults and patients with chronic lymphocytic B-cell leukemia (PBL-B)].
Roliński J; Rupniewska ZM; Wasik-Szczepanek E
Pol Arch Med Wewn; 1999 Apr; 101(4):307-14. PubMed ID: 10740408
[TBL] [Abstract][Full Text] [Related]
17. B-zone small lymphocytic lymphoma: a morphologic, immunophenotypic, and clinical study with comparison to "well-differentiated" lymphocytic disorders.
Carbone A; Pinto A; Gloghini A; Volpe R; Zagonel V
Hum Pathol; 1992 Apr; 23(4):438-48. PubMed ID: 1563746
[TBL] [Abstract][Full Text] [Related]
18. Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies.
Rossmann ED; Lundin J; Lenkei R; Mellstedt H; Osterborg A
Hematol J; 2001; 2(5):300-6. PubMed ID: 11920265
[TBL] [Abstract][Full Text] [Related]
19. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
[TBL] [Abstract][Full Text] [Related]
20. PD-1 Expression in Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) and Large B-cell Richter Transformation (DLBCL-RT): A Characteristic Feature of DLBCL-RT and Potential Surrogate Marker for Clonal Relatedness.
He R; Ding W; Viswanatha DS; Chen D; Shi M; Van Dyke D; Tian S; Dao LN; Parikh SA; Shanafelt TD; Call TG; Ansell SM; Leis JF; Mai M; Hanson CA; Rech KL
Am J Surg Pathol; 2018 Jul; 42(7):843-854. PubMed ID: 29762141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
